Hormonal regulation of human muscle protein metabolism

Annual Review of Nutrition

Volumn 17, Issue , 1997, Pages 457-485

  Rooyackers, Olav E ^a   Nair, K Sreekumaran ^a  

^a MAYO CLINIC   (United States)

Author keywords

Growth hormone; Insulin; Protein breakdown; Protein synthesis; Skeletal muscle

Indexed keywords

CATECHOLAMINE; GLUCOCORTICOID; GROWTH HORMONE; PROSTAGLANDIN; PROTEIN; SOMATOMEDIN; TESTOSTERONE; THYROID HORMONE;

AMINO ACID ANALYSIS; GLUCAGON BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE ATROPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SKELETAL MUSCLE; THYROID HORMONE BLOOD LEVEL;

ADULT; GLUCAGON; GLUCOCORTICOIDS; HORMONES; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MUSCLE PROTEINS;

ANIMALIA;

EID: 0030802370     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.17.1.457     Document Type: Review

References (173)

1. Adamo ML. 1995. Regulation of insulinlike growth factor 1 gene expression. Diabetes Rev. 3:2-27
2. Adlerberth A, Angeras U, Jagenberg R, Lindstedt G, Stenstr_m G, Hasselgren P. 1987. Urinary excretion of 3-methyl-histidine and creatinine and plasma concentrations of amino acids in hyperthyroid patients following preoperative treatment with antithyroid drug or β-blocking agent: results from a prospective, randomized study. Metabolism 36: 637-42
3. Alberti KGMM, Batstone GF, Foster KJ, Johnston DG. 1980. Relative role of various hormones in mediating the metabolic response to injury. J. Parenter. Enter. Nutr. 4:141-46
4. Alvestrand A, Defronzo RA, Smith D, Wahren J. 1988. Influence of hyperinsulinaemia on intracellular amino acid levels and amino acid exchange across splanchnic and leg tissues in uraemia. Clin. Sci. 74:155-63
5. Arfvidsson B, Zachrisson H, Möller-Loswick AC, Hyltander A, Sandström R, Lundholm K. 1991. Effect of systemic hyperinsulinemia on amino acid flux across human legs in postabsorptive state. Am. J. Physiol. 260:E46-52
6. Bach LA, Rechler MM. 1995. Insulin-like growth factor binding proteins. Diabetes Rev. 3:38-61
7. Baillie AGS, Garlick PJ. 1991. Attenuated responses of muscle protein synthesis to fasting and insulin in adult female rats. Am. J. Physiol. 262:E1-5
8. Barrett EJ, Gelfand RA. 1989. The in vivo study of cardiac and skeletal muscle protein turnover. Diabetes Metab. Rev. 5:133-48
9. Barrett EJ, Revkin JH, Young LH, Zaret BL, Jacob R, Gelfand RA. 1987. An isotopic method for measurement of muscle protein synthesis and degradation in vivo. Biochem. J. 245:223-28
10. Baumann PQ, Stirewalt WS, O'Rourke BD, Howard D, Nair KS. 1994. Precursor pools of protein synthesis: a stable isotope study in a swine model. Am. J. Physiol 267:E203-9
11. Beaufrere B, Horber FF, Schwenk WF, March HM, Matthews D, et al. 1989. Glucocorticosteroids increase leucine oxidation and impair leucine balance in hu-mans. Am. J. Physiol. 257:E712-21
12. Beckett AH. 1992. Muscling in on clenbuterol. Lancet 340:403 (Lett.)
13. Bennet WM, Connacher AA, Jung RT, Stehle P, Rennie MJ. 1991. Effects of insulin and amino acids on leg protein turnover in IDDM patients. Diabetes 40:499-508
14. Bennet WM, Connacher AA, Scrimgeour CM, Jung RT, Rennie MJ. 1990. Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissue during hyperaminoacidemia. Am. J. Physiol 259:E185-94
15. 13C]leucine. Diabetologia 33: 43-51
16. Berneis K, Keller U. 1996. Metabolic actions of growth hormone: direct and indirect. Bailliere Clin. Endocrinol. 10:337-52
17. Bessey PQ, Lowe KA. 1993. Early hormonal changes affect the catabolic response to trauma. Ann. Surg. 218:476-91
18. Bhasin S, Storer T, Berman N, Callegari C, Clevenger B, et al. 1996. The effects of supraphysiological doses of testosterone on muscle size and strength in normal men. New Engl. J. Med. 335:1-7
19. Bier DM. 1989. Intrinsically difficult problems: the kinetics of body proteins and amino acids in man. Diabetes Metab. Rev. 5:111-32
20. Biolo G, Chinkes D, Zhang X-J, Wolfe RR. 1992. A new method to determine in vivo the relationship between amino acid transmebrane transport and protein kinetics in muscle. J. Parenter. Enter. Nutr. 16:305-15
21. Biolo G, Fleming DRY, Wolfe RR. 1995. Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J. Clin. Invest. 95:811-19
22. Bistrian BR, Schwartz J, Istfan NW. 1992. Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation. Proc. Soc. Exp. Biol. Med. 200:233-39
23. Black PR, Brooks DC, Bessey PQ, Wolfe RR, Wilmore DW. 1982. Mechanisms of insulin resistance following injury. Ann. Surg. 196:420-35
24. Bowes SB, Benn JJ, Scobie IN, Umpleby AM, Lowy C, Sönksen PH. 1993. Leucine metabolism in patients with Cushing's syndrome before and after successful treatment. Clin. Endocrinol. 39:591-98
25. Brillon DJ, Zheng B, Campbell RG, Matthews DE. 1995. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am. J. Physiol. 268:E501-13
26. Brodsky IG, Balagopal P, Nair KS. 1996. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men. J. Clin. Endo. Metab. 81:3469-75
27. Brown J, Gore DC, Lee R. 1993. Dichloroacetate inhibits peripheral efflux of pyruvate and alanine during hormonally simulated catabolic stress. J. Surg. Res. 54:592-96
28. Brown JA, Gore DC, Jahoor F. 1994. Catabolic hormones alone fail to reproduce the stress-induced efflux of amino acids. Arch. Surg. 129:819-24
29. Cahill GF. 1970. Starvation in man. New Engl. J. Med. 282:668-75
30. Celotti F, Cesi PN. 1992. Anabolic steroids: a review of their effects on the muscles, of their possible mechanism of action and of their use in athletics. J. Steroid Biochem. Molec. Biol. 43:469-77
31. Charlton MR, Adey DB, Nair KS. 1996. Evidence for a catabolic role of glucagon during an amino acid load. J. Clin. Invest. 98:90-99
32. Charlton MR, Balagopal P, Nair KS. 1996. Skeletal muscle myosin heavy chain synthesis rate in type I diabetic patients. Diabetes 45 (Suppl. 2):98A (Abstr.)
33. 15N]leucine and the forearm model. Eur. J. Clin. Invest. 15:349-54
34. 15N]leucine as a tracer. Clin. Sci. 73:241-46
35. Collipp PJ, Curti V, Thomas J, Sharma RK, Maddaiah VT, Cohn SH. 1973. Body composition changes in children receiving human growth hormone. Metabolism 22:589-95
36. Copeland KC, Nair KS. 1994. Acute growth hormone effects on amino acid and lipid metabolism. J. Clin. Endocrinol. Metab. 78:1040-47
37. Copeland KC, Nair KS. 1995. Effects of rhGH on glucose, lipid, and amino acid metabolism. In GHRH, GH and IGF-1, ed. MR Blackman, SM Harman, J Roth, JR Shapiro, pp. 185-94. New York: Springer
38. Couet C, Fukagawa NK, Matthews DE, Bier DM, Young VR. 1990. Plasma amino acid kinetics during acute states of glucagon deficiency and excess in healthy adults. Am. J. Physiol. 258:E78-85
39. Crispell KR, Parson W, Hollifield G. 1955. A study of the rate of protein synthesis before and during the administration of L-triiodothyronine to patients with myxedema and healthy volunteers using N-15 glycine. J. Clin. Invest. 35:164-69
40. Crown AL, Holly JMP. 1995. The insulinlike growth factor system in critical illness-pathophysiology and therapeutic potential. Clin. Nutr. 14:321-28
41. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH. 1991. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J. Appl. Physiol 70:688-94
42. Darmaun D, Matthews DE, Bier DM. 1988. Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production. Am. J. Physiol. 255:E366-73
43. Del Prato S, DeFronzo RA, Castellino P, Wahren J. Alvestrand A. 1990. Regulation of amino acid metabolism by epinephrine. Am. J. Physiol. 258:E878-87
44. Denne SC, Brechtel G, Johnson A, Liechty EA, Baron AD. 1995. Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy. J. Clin. Endocrinol. Metab. 80:2371-77
45. Denne SC, Liechty EA, Liu YM, Brechtel G, Baron AD. 1991. Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults. Am. J. Physiol. 261:E809-14
46. Elahi D, McAloon-Dyke M, Fukagawa NK, Sclater AL, Wong GA, et al. 1993. Effects of recombinant human IGF-I on glucose and leucine kinetics in men. Am. J. Physiol. 265:E831-38
47. Fitzpatrick GF, Meguid MM, Gitlitz PH, Brennan MF. 1977. Glucagon infusion in normal man: effects on 3-methylhistidine excretion and plasma amino acids. Metabolism 26:477-85
48. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. 1989. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J. Clin. Invest. 83:1614-22
49. Florini JR. 1970. Effects of testosterone on qualitative pattern of protein synthesis in skeletal muscle. Biochemistry 9:909-12
50. Florini JR. 1987. Hormonal control of muscle growth. Muscle Nerve 10:577-98
51. Florini JR, Ewton DZ, McWade FJ. 1995. IGFs, muscle growth, and myogenesis. Diabetes Rev. 3:73-92
52. Forbes GB. 1985. The effect of anabolic steroids on lean body mass: the dose response curve. Metabolism 34:571-73
53. Forbes GB. 1987. Human Body Composition. Growth, Aging, Nutrition, and Activity. New York: Springer. 350 pp.
54. Forbes GB. 1987. Influence of hormones. See Reference 52, pp. 267-81
55. Fryburg DA. 1994. Insulin-like growth factor 1 exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am. J. Physiol. 267:E331-36
56. Fryburg DA. 1996. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to Igf-I. Possible role of nitric oxide in muscle protein synthesis. J. Clin. Invest. 97:1319-28
57. Fryburg DA, Barrett EJ. 1993. Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metabolism 42:1223-27
58. Fryburg DA, Barrett EJ. 1995. Insulin, growth hormone, and IGF-I regulation of protein metabolism. Diabetes Rev. 3:93-112
59. Fryburg DA, Barret EJ, Louard RJ, Gelfand RA. 1990. Effect of starvation on human muscle protein metabolism and its response to insulin. Am. J. Physiol. 259:E477-82
60. Fryburg DA, Gelfand RA, Barrett EJ. 1991. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am. J. Physiol. 260:E499-504
61. Fryburg DA, Gelfand RA, Jahn LA, Oliveras D, Sherwin RS, et al. 1995. Effects of epinephrine on human muscle glucose and protein metabolism. Am. J. Physiol. 268:E55-59
62. Fryburg DA, Jahn LA, Hill SA, Oliveras DM, Barrett EJ. 1995. Insulin and insulin-like growth factor-1 enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. J. Clin. Invest. 96:1722-29
63. Fryburg DA, Louard RJ, Gerow KE, Gelfand RA, Barrett EJ. 1992. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes 41:424-29
64. Garlick PJ, Baillie AGS, Grant I, McNurlan MA. 1992. In-vivo action of insulin on protein metabolism in experimental animals. In Protein Metabolism in Diabetes Mellitus, ed. KS Nair, pp. 15-25. London: Smith-Gordon
65. Garlick PJ, Burns HJ, Palmer RM. 1988. Regulation of muscle protein turnover: possible implications for modifying the responses to trauma and nutrient intake. Bailliere Clin. Gastroenterolog. 2:915-40
66. Garlick PJ, Mcnurlan MA, Essén P, Wernerman J. 1994. Measurement of tissue protein synthesis rates in vivo: a critical analysis of contrasting methods. Am. J. Physiol. 266:E287-97
67. 13C]leucine. Clin. Sci. 77:329-36
68. Gelfand RA, Barret EJ. 1987. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J. Clin. Invest. 80:1-6
69. Gelfand RA, Hutchinson-Williams KA, Bonde AA, Castellino P, Sherwin RS. 1987. Catabolic effect of thyroid hormone excess: the contribution of adrenergic activity to hypermetabolism and protein breakdown. Metabolism 36:562-69
70. Gelfand RA, Matthews DE, Bier DM, Sherwin RS. 1984. Role of counterregulatory hormones in the catabolic response to stress. J. Clin. Invest. 74:2238-48
71. 2α availability. Eur. J. Clin. Invest. 21:406-12
72. Goodman MN. 1991. Tumor necrosis factor induces skeletal protein breakdown in rats. Am. J. Physiol. 260:E727-30
73. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. 1991. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch. Surg. 126:38-43
74. Gore DC, Jahoor F, Wolfe RR, Herndon DN. 1993. Acute response of human muscle protein to catabolic hormones. Ann. Surg. 218:679-84
75. Griggs RC, Halliday D, Kingston W, Moxley RT. 1986. Effect of testosterone on muscle protein synthesis in myotonic dystrophy. Ann. Neurol. 20:590-96
76. Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D. 1989. Effect of testosterone on muscle mass and muscle protein synthesis. J. Appl. Physiol 66:498-503
77. Hasselgren PO, Adlerberth A, Angeras U, Stenstrom G. 1984. Protein metabolism in skeletal muscle tissue from hyperthyroid patients after preoperative treatment with antithyroid drug or selective β-blocking agent. Results from a prospective, randomized study. J. Clin. Endocrinol. Metab. 59:835-39
78. Heslin MJ, Newman E, Wolf RF, Pisters PWT, Brennan MF. 1992. Effect of hyperinsulinemia on whole body and skeletal muscle leucine carbon kinetics in humans. Am. J. Physiol. 262:E911-18
79. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. 1983. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am. J. Clin. Nutr. 37:478-94
80. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, et al. 1990. Appendicular skeletal muscle mass: measurement by duaphoton absorptiometry. Am. J. Clin. Nutr. 52:214-18
81. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. 1993. Testosterone administration increases insulin-like growth factor-1 levels in normal men. J. Clin. Endocrinol. Metab. 77:776-79
82. Horber FF, Haymond MW. 1990. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J. Clin. Invest. 86:265-72
83. Horber FF, Scheidegger JR, Grünig BE, Frey FJ. 1985. Thigh muscle mass and function in patients treated with glucocorticoids. Eur. J. Clin. Invest. 15:302-7
84. Jensen MD, Kanaley JA, Roust LR, O'Brien PC, Braun JS, et al. 1993. Assessment of body composition with use of dual-energy X-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin. Proc. 68:867-73
85. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, et al. 1989. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-25
86. Jorgensen JO, Thuesen L, Müller J, Ovesen P, Skakkebaek NE, Christiansen JS. 1994. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur. J. Endocrinol. 130:224-28
87. Karinch AM, Kimball SR, Antonetti DA, Jefferson LS. 1992. Mechanism of insulin action on protein synthsis: translational regulation. In Protein Metabolism in Diabetes Mellitus. ed. KS Nair, pp. 139-48. London: Smith-Gordon
88. Kettelhut IC, Wing SS, Goldberg AL. 1988. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab. Rev. 4:751-72
89. Kissel JT, Mendell JR. 1992. The endocrine myopathies. Myopathies 18(62): 527-51
90. Kraenzlin ME, Keller U, Keller A, Thélin A, Arnaud MJ, Stauffacher W. 1989. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via β-adrenergic mechanisms. J. Clin. Invest. 84:388-93
91. Louard RJ, Bhushan R, Gelfand RA, Barrett EJ, Sherwin RS. 1994. Glucocorticoids antagonize insulin's antiproteolytic action on skeletal muscle in humans. J. Clin. Endocrinol. Metab. 79:278-84
92. Louard RJ, Fryburg DA, Gelfand RA, Barrett EJ. 1992. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. J. Clin. Invest. 90:2348-54
93. Loughna PT, Mason P, Bates PC. 1992. Regulation of insulin-like growth factor 1 gene expression in skeletal muscle. Symp. Soc. Exp. Biol. 46:319-30
94. Lundholm K, Edström S, Ekman L, Karlberg I, Walker P, Schersten T. 1981. Protein degradation in human skeletal muscle tissue: the effect of insulin, leucine, amino acids and ions. Clin. Sci. 60:319-26
95. Lundholm K, Schersten T. 1977. Protein synthesis in human skeletal muscle tissue: influence of insulin and amino acids. Eur. J. Clin. Invest. 7:531-36
96. Lykken GI, Jacob RA, Munoz JM, Sandstead HH. 1980. A mathematical model of creatine metabolism in normal males - comparison between theory and experiment. Am. J. Clin. Nutr. 33:2674-85
97. Marchesini G, Forlani G, Zoli M, Vannini P, Pisi E. 1982. Muscle protein breakdown in uncontrolled diabetes as assessed by urinary 3-methylhistidine excretion. Diabetologia 23:456-58
98. Matthews DE, Bier DM, Rennie MJ, Edwards RHT, Halliday D, et al. 1981. Regulation of leucine metabolism in man: a stable isotope study. Science 214:1129-31
99. 13C]leucine. Am. J. Physiol. 238:E473-79
100. Matthews DE, Pesola G, Campbell RG. 1990. Effect of epinephrine on amino acid and energy metabolism in humans. Am. J. Physiol. 258:E948-56
101. McNulty PH, Louard RJ, Deckelbaum LI, Zaret BL, Young LH. 1995. Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance. Circulation 92:2151-56
102. McNurlan MA, Essén P, Heys SD, Buchan V, Garlick PJ, Wernerman J. 1991. Measurement of protein synthesis in human skeletal muscle: further investigation of the flooding technique. Clin. Sci. 81:557-64
103. 5]phenylalanine. Am. J. Physiol. 267:E102-8
104. Miles JM, Nissen SL, Gerich JE, Haymond MW. 1984. Effects of epinephrine infusion on leucine and alanine kinetics in humans. Am. J. Physiol. 247:E166-72
105. Millward DJ, Halliday D, Rennie MJ. 1984. The extent of protein synthesis in muscle in man. Hum. Nutr. Clin. Nutr. 38C:151-54 (Reply)
106. Möller-Loswick AC, Zachrisson H, Hyltander A, Körner U, Matthews DE, Lundholm K. 1994. Insulin selectively attenuates breakdown of nonmyofibrillar proteins in peripheral tissues of normal men. Am. J. Physiol. 266:E645-52
107. Mooradian AD, Morley JE, Korenman SG. 1987. Biological actions of androgens. Endocrinol. Rev. 8:1-28
108. Morrison WL, Gibson JNA, Jung RT, Rennie MJ. 1988. Skeletal muscle and whole body protein turnover in thyroid disease. Eur. J. Clin. Invest. 18:62-68
109. Müller MJ, Seitz HJ. 1984. Thyroid hormone action on intermediary metabolism. Part III. Protein metabolism in hyperand hypothyroidism. Klin. Wochenschr. 62:97-102
110. Beckett AH. 1992. Comments: Muscling in on clenbuterol. Lancet 340:403
111. Nair KS. 1984. Energy and Protein Metabolism in Diabetes and Obesity. London: Council of National Academic Awards. 190 pp.
112. Nair KS, Ford GC, Ekberg K, FernqvistForbes E, Wahren J. 1995. Protein dynamics in whole body and in splanchnic and leg tissues in type 1 diabetic patients. J. Clin. Invest. 95:2926-37
113. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. 1983. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25:400-3
114. Nair KS, Halliday D, Griggs RC. 1988. Leucine incorporation into mixed skeletal muscle protein in humans. Am. J. Physiol. 254:E208-13
115. Nair KS, Halliday D, Matthews DE, Welle SL. 1987. Hyperglucagonemia during insulin deficiency accelerates protein catabolism. Am. J. Physiol. 253:E208-13
116. Nair KS, Schwartz RG, Welle S. 1992. Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans. Am. J. Physiol. 263:E928-34
117. Newman E, Heslin MJ, Wolf RF, Pisters PW, Brennan MF. 1994. The effect of systemic hyperinsulinemia with concomitant amino acid infusion on skeletal muscle protein turnover in the human forearm. Metabolism 43:70-78
118. Pacy PJ, Bannister PA, Halliday D. 1991. Influence of insulin on leucine kinetics in the whole body and across the forearm in post-absorptive insulin dependent diabetic (type 1) patients. Diabetes Res. 18:155-62
119. Pacy PJ, Cheng KN, Ford GC, Halliday D. 1990. Influence of glucagon on protein and leucine metabolism: a study in fasting man with induced insulin resistance. Br. J. Surg. 77:791-94
120. Pacy PJ, Nair KS, Ford C, Halliday D. 1989. Failure of insulin infusion to stimulate fractional muscle protein synthesis in type 1 diabetic patients. Anabolic effect of insulin and decreased proteolysis. Diabetes 38:618-24
121. Palmer RM. 1990. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandin Leuk. Essent. Fatty Acids 39:95-104
122. Pearlstone DB, Wolf RF, Berman RS, Burt M, Brennan MF. 1994. Effect of systemic insulin on protein kinetics in postoperative cancer patients. Ann. Surg. Oncol. 1:321-32
123. Pozefsky T, Felig P, Tobin JD, Soeldner JS, Cahill GF. 1969. Amino acid balance across tissue of forearm in postabsorptive man. Effects of insulin at two dose levels. J. Clin. Invest. 48:2273-82
124. Preedy VR, Garlick PJ. 1985. The effect of glucagon administration on protein synthesis in skeletal muscles, heart and liver in vivo. Biochem. J. 228:575-81
125. Preedy VR, Garlick PJ. 1988. Inhibition of protein synthesis by glucagon in different rat muscles and protein fractions in vivo and in the perfused rat hemicorpus. Biochem. J. 251:727-32
126. Ramsay ID. 1966. Muscle dysfunction in hyperthyroidism. Lancet 2:931-34
127. Rathmacher JA, Flakoll PJ, Nissen SL. 1995. A compartimental model of 3-methylhistidine metabolism in humans. Am. J. Physiol. 269:E193-98
128. Reeds PJ, Fjeld CR, Jahoor F. 1994. Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J. Nutr. 124:906-10
129. Reeds PJ, Hay SM, Glennie RT, Mackie WS, Garlick PJ. 1985. The effect of indomethacin on the stimulation of protein synthesis by insulin in young postabsorptive rats. Biochem. J. 227:255-61
130. 2α in the stimulation of muscle protein synthesis by insulin. Biochem. Biophys. Res. Commun. 116:1084-90
131. Rennie MJ. 1985. Muscle protein turnover and the wasting to injury and disease. Br. Med. Bull. 41:257-64
132. Rennie MJ, Bennegård K, Edén E, Emery PW, Lundholm K. 1984. Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation. Metabolism 33:250-56
133. Rennie MJ, Edwards RHT, Halliday D, Matthews DE, Wolman SL, Millward DJ. 1982. Muscle protein synthesis measured by stable isotope techniques in man: the effect of feeding and starvation. Clin. Sci. 63:519-23
134. Rennie MJ, Millward DJ. 1983. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown. Clin. Sci. 65:217-25
135. Rennie MJ, Smith K, Watt PW. 1994. Measurement of human tissue protein synthesis: an optimal approach. Am. J. Physiol. 266:E298-307
136. Rifai Z, Welle S, Moxley RT, Lorenson M, Griggs RC. 1995. Effect of prednisone on protein metabolism in Duchenne dystrophy. Am. J. Physiol. 268:E67-74
137. Robert JJ, Beaufrere B, Koziet J, Desjeux JF, Bier DM, et al. 1985. Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine, alanine, and glycine. Diabetes 34:67-73
138. Rodier M, Richard JL, Bringer J, Cavalié G, Bellet H, Mirouze J. 1984. Thyroid status and muscle protein breakdown as assessed by urinary 3-methylhistidine excretion: study in thyrotoxic patients before and after treatment. Metabolism 33:97-100
139. Ruff RL, Weissmann J. 1988. Endocrine myopathies. Neurol. Clin. 6:575-92
140. Sakurai Y, Aarsland A, Herndon DN, Chinkes DL, Pierre E, et al. 1995. Stimulation of muscle protein synthesis by longterm insulin infusion in severely burned patients. Ann. Surg. 222:283-97
141. Salomon F, Cuneo RC, Hesp R, Sönksen PH. 1989. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New Engl. J. Med. 321:1797-803
142. Schwartz RS. 1995. Throphic factor supplementation: effect on the ageassociated changes in body composition. J. Gerontol. 50A: 151-56 (Special issue)
143. Schwenk WF, Beaufrere B, Haymond MW. 1985. Use of reciprocal pool specific activities to model leucine metabolism in humans. Am. J. Physiol. 249:E646-50
144. Sjölin J, Stjernström H, Arturson G, Andersson E, Friman G, Larsson J. 1989. Exchange of 3-methylhistidine in the splanchnic region in human infection. Am. J. Clin. Nutr. 50:1407-14
145. 13C]valine. Am. J. Physiol. 262:E372-76
146. Stiegler H, Rett K, Wicklmayr M, Mehnert H. 1989. Metabolic effects of prostaglandin E1 on human skeletal muscle with special regard to the amino acid metabolism. Vasa 28 (Suppl.). 14-18
147. Sugden PH, Fuller SJ. 1991. Review article. Regulation of protein turnover in skeletal and cardiac muscle. Biochem. J. 273:21-37
148. Tessari P, Biolo G, Inchiostro S, Sacca L, Nosadini R, et al. 1990. Effects of insulin on whole body and forearm leucine and KIC metabolism in type 1 diabetes. Am. J. Physiol. 259:E96-103
149. Tessari P, Inchiostro S, Biolo G, Marescotti MC, Fantin G, et al. 1989. Leucine kinetics and the effects of hyperinsulinemia in patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 68:256-62
150. Tessari P, Inchiostro S, Biolo G, Vincenti E, Sabadin L. 1991. Effects of acute systemic hyperinsulinemia on forearm muscle proteolysis in healthy man. J. Clin. Invest. 88:27-33
151. Tessari P, Nosadini R, Trevisan R, De Kreutzenberg SV, Inchiostro S, et al. 1986. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. J. Clin. Invest. 77:1797-804
152. Umpleby AM, Boroujerdi MA, Brown PM, Carson ER, Sönksen PH. 1986. The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients. Diabetologia 29:131-41
153. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, et al. 1995. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am. J. Physiol. 269:E820-26
154. Vlachopapadopoulou E, Zachwieja JJ, Gertner JM, Manzione D, Bier DM, et al. 1995. Metabolic and clinical response to recombinant human insulin-like growth factor 1 in myotonic dystrophy - a clinical research center study. J Clin. Endocrinol. Metab. 80:3715-23
155. Voerman HJ, Strack van Schijndel RJM, De Boer H, Van der Veen EA, Thijs LG. 1992. Growth hormone: secretion and administration in catabolic adult patients, with emphasis on the critically ill patient. Neth. J. Med. 41:229-44
156. Waterlow JC. 1984. Protein turnover with special reference to man. Q. J. Exp. Physiol. 69:409-38
157. Waterlow JC, Garlick PJ, Millward DJ. 1978. Protein Turnover in Mammalian Tissues and in the Whole Body. Amsterdam: Elsevier. 804 pp.
158. Watt PW, Corbett ME, Rennie MJ. 1992. Stimulation of protein synthesis in pig skeletal muscle by infusion of amino acids during constant insulin availability. Am. J. Physiol. 263:E453-60
159. Watt PW, Lindsay Y, Scrimgeour CM, Chien PAF, Gibson JNA, et al. 1991. Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: use in studies of human tissue protein synthesis. Proc. Natl. Acad. Sci. USA 88:5892-96
160. Welle S, Thornton C, Jozefowicz R, Statt M. 1993. Myofibrillar protein synthesis in young and old men. Am. J. Physiol. 264:E693-98
161. Welle S, Thornton C, Statt M, McHenry B. 1996. Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin. Endocrinol. Metab. 81:3239-43
162. Wilmore DW, Black PR, Muhlbacher F. 1983. Injured man: trauma and sepsis. In Nutritional Support of the Seriously III Patients, ed. RW Winters, HL Greene, pp. 33-52. London: Acadamic
163. Wolf RF, Heslin MJ, Newman E, Pearlstone DB, Gonenne A, Brennan MF. 1992. Growth hormone and insulin combine to improve whole-body and skeletal muscle protein kinetics. Surgery 112:284-92
164. Wolfe BR, Culebas JM, Aoki TT, O'Conner NE, Finley RJ, et al. 1979. The effect of glucagon on protein metabolism in normal man. Surgery 86:248-57
165. Wolfe RR. 1992. Assessment of body composition. In Radioactive and Stable Isotope Tracers in Biomedicine. Principles and Practice of Kinetic Analysis, pp. 189-97. New York: Wiley-Liss
166. Yarasheski KE. 1994. Growth hormone effects on metabolism, body composition, muscle mass, and strength. Exerc. Sport Sci. Rev. 22:285-312
167. Yarasheski KE, Campbell JA, Smith K, Rennie MJ, Holloszy JO, Bier DM. 1992. Effect of growth hormone and resistance exercise on muscle growth in young men. Am. J. Physiol. 262:E261-67
168. Yarasheski KE, Zachweija JJ, Angelopoulos TJ, Bier DM. 1993. Shortterm growth hormone treatment does not increase muscle protein synthesis in experienced weight lifters. J. Appl. Physiol. 74:3073-76
169. Yarasheski KE, Zachwieja JJ, Bier DM. 1993. Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women. Am. J. Physiol. 265:E210-14
170. Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM. 1995. Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am. J. Physiol. 268:E268-76
171. Yates RO, Connor H, Woods HF. 1981. Muscle protein breakdown in thyrotoxicosis assessed by urinary 3-methylhistidine excretion. Ann. Nutr. Metab. 25:262-67
172. Young VR, Alexis SD, Baliga BS, Munro HN, Muecke W. 1972. Metabolism of administered 3-methylhistidine. Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-methylhistidine and its N-acetyl derivative. J. Biol. Chem. 247:3592-600
173. Zürcher RM, Horber FF, Grünig BE, Frey FJ. 1989. Effect of thyroid dysfunction on thigh muscle efficiency. J. Clin. Endocrinol. Met. 69:1082-86